OpenBilldrug price receipt

NADAC week of 2026-10-14

PANTOPRAZOLE SODIUM 40 MG VIAL

For 1 unit (EA)

Pharmacies pay

$2.37 filed

1 × $2.374 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-03-18 · as of 2026-10-14 · retrieved 2026-10-17

Medicare

We don’t know yet

No Medicare reference price. Part D: OpenBill did not match this NDC to a usable Medicare Part D spending row. Either Part D has none for it, or the rows that share its name could not safely be tied to it (for example, they mix units, routes or release forms, or the drug is sold over the counter, which Part D does not cover). Part B: This NDC is not in the current quarter’s Medicare Part B NDC-HCPCS crosswalk, so it has no Part B payment limit.


The spread

We don’t know yet

There is no Medicare figure to compare with, so there is no spread.

Cost-plus estimate

$7.73 estimated

$2.37 + $0.36 (15%) + $5.00 fee per fill = $7.73

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-03-18 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

PANTOPRAZOLE SODIUM 40 MG VIAL is how the CMS NADAC file names this product. The FDA NDC Directory lists it as pantoprazole sodium, under the trade name “PANTOPRAZOLE SODIUM I.V.”.

FDA gives its dosage form as “injection, powder, lyophilized, for solution” and “injection, powder, for solution” and its route as intravenous.

FDA lists 9 labelers (the companies named on the label) for its NDCs, among them Hikma Pharmaceuticals USA Inc., Sagent Pharmaceuticals and Camber Pharmaceuticals, Inc.

FDA’s Established Pharmacologic Class for it is Proton Pump Inhibitor.

The NADAC file of 2026-10-14 prices it under 11 NDCs (National Drug Codes); the FDA directory lists 10 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $2.37 for 1 unit (EA) (1 × $2.374 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-03-18. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation codes for it: 4, carried forward from the previous file; 5, calculated based on package size; 6, the CMS Covered Outpatient Drug Product File S/I/N drug category was not applied when grouping drugs for the calculation.

The NADAC of all 11 NDCs was carried forward from an earlier file (NADAC explanation code 2 or 4), not newly surveyed: those prices took effect on 2026-03-18. The file is new; the price is not.

The 9 labelers

LabelerNDCsPharmacies pay per unit
Hikma Pharmaceuticals USA Inc.2$2.374 per EA filed
BE Pharmaceuticals Inc.1$2.374 per EA filed
Camber Pharmaceuticals, Inc.1$2.374 per EA filed
Eugia US LLC1$2.374 per EA filed
Meitheal Pharmaceuticals Inc.1$2.374 per EA filed
Northstar Rx LLC1$2.374 per EA filed
Piramal Critical Care1$2.374 per EA filed
Sagent Pharmaceuticals1$2.374 per EA filed
Sun Pharmaceutical Industries, Inc.1$2.374 per EA filed
Not listed as a package in the FDA directory1$2.374 per EA filed
All 11 NDCs, with labeler and price
  • 00143-9284-10 · Hikma Pharmaceuticals USA Inc. · $2.374 per EA · eff. 2026-03-18 filed carried forward
  • 00143-9300-10 · Hikma Pharmaceuticals USA Inc. · $2.374 per EA · eff. 2026-03-18 filed carried forward
  • 25021-0751-10 · Sagent Pharmaceuticals · $2.374 per EA · eff. 2026-03-18 filed carried forward
  • 31722-0204-10 · Camber Pharmaceuticals, Inc. · $2.374 per EA · eff. 2026-03-18 filed carried forward
  • 55150-0202-10 · Eugia US LLC · $2.374 per EA · eff. 2026-03-18 filed carried forward
  • 65219-0433-15 · not listed as a package in the FDA directory · $2.374 per EA · eff. 2026-03-18 filed carried forward
  • 66794-0258-41 · Piramal Critical Care · $2.374 per EA · eff. 2026-03-18 filed carried forward
  • 70095-0024-02 · Sun Pharmaceutical Industries, Inc. · $2.374 per EA · eff. 2026-03-18 filed carried forward
  • 71288-0600-11 · Meitheal Pharmaceuticals Inc. · $2.374 per EA · eff. 2026-03-18 filed carried forward
  • 71839-0122-10 · BE Pharmaceuticals Inc. · $2.374 per EA · eff. 2026-03-18 filed carried forward
  • 72603-0128-10 · Northstar Rx LLC · $2.374 per EA · eff. 2026-03-18 filed carried forward

Other strengths, forms and brands

6 other products in the NADAC file share the FDA nonproprietary name pantoprazole sodium with PANTOPRAZOLE SODIUM 40 MG VIAL.

ProductPharmacies pay per unitMedicare per unit
PANTOPRAZOLE DR 40 MG SUSP PKT
generic · for suspension / granule, delayed release / suspension
$3.84903 per EA filed
eff. 2026-09-23 to 2026-09-30
We don’t know yet
PANTOPRAZOLE SOD DR 20 MG TAB
generic · tablet, delayed release
$0.04262 per EA filed
eff. 2026-09-23
$0.19866 per EA filed
Part D 2024 average
PANTOPRAZOLE SOD DR 40 MG TAB
generic · tablet, delayed release / tablet
$0.03577 per EA filed
eff. 2026-09-23
$0.19866 per EA filed
Part D 2024 average
PANTOPRAZOLE SODIUM 40 MG VIAL this page
generic · injection, powder, lyophilized, for solution / injection, powder, for solution
$2.374 per EA filed
eff. 2026-03-18
We don’t know yet
PROTONIX 40 MG SUSPENSION
brand · granule, delayed release
$14.06629 per EA filed
eff. 2026-09-23
We don’t know yet
PROTONIX DR 20 MG TABLET
brand · tablet, delayed release
$14.31343 per EA filed
eff. 2026-01-01
We don’t know yet
PROTONIX DR 40 MG TABLET
brand · tablet, delayed release
$14.23539 per EA filed
eff. 2026-09-23
We don’t know yet

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. between 2026-01-01 and 2026-09-30 (4 dates) · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 11 NDCs’ NADAC prices is $2.374 per EA filed.

Of the 61 other products in FDA’s Proton Pump Inhibitor class priced per EA, 29 have a higher middle NADAC price and 32 a lower one. The one in the middle is NAPROXEN-ESOMEPRAZ DR 500-20 MG, at $1.95826 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-03-18, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

We don’t know yet; the card above says why.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why does this page start at 1 unit (EA)?
NADAC prices this product per EA, and the FDA NDC Directory lists 10 of its 11 NDCs (it does not list the other one) as dosage forms “INJECTION, POWDER, FOR SOLUTION”, “INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION” with route “INTRAVENOUS”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and none of these is one. NADAC’s EA for it may be a whole package (such as a kit, pen, syringe, vial or inhaler) or one dose inside it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.